Treatment of Advanced Melanoma: Past, Present and Future
Therapeutic options for treating advanced melanoma are progressing rapidly. Until six years ago, the regimen for treating advanced melanoma mainly comprised cytotoxic agents such as dacarbazine, and type I interferons. Since 2014, anti-programmed cell death 1 (PD1) antibodies have become recognized...
| Published in: | Life |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-09-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/10/9/208 |